Japan-based Olympus Corporation has partnered with MedTech Innovator Asia Pacific, the industry's largest healthcare accelerator, to facilitate the Olympus Asia Pacific Innovation Programme (OAIP) running throughout 2023.

Olympus invites visionary startups to contribute to this revolution by participating in the OAIP and submitting their technologies that play a meaningful role in the advancement of minimally invasive care and new ways to detect, monitor, and treat conditions and diseases.

Shortlisted startups will be invited to pitch across various in-person and virtual pitch events in front of Olympus executives and leaders over two phases from May 2023 to September 2023, with the winning innovator receiving grant funding of $75,000 as well as an exclusive mentorship program with key thought leaders from within Olympus.

Visionaries are invited to submit solutions that play a meaningful role in the advancement of minimally invasive care and new ways to detect, monitor, and treat conditions and diseases. Of particular interest are technologies focused on cancers and diseases of the stomach, colon, and lungs, and within the urology specialty. Examples may include smart endoscopy, Robotics, sensing, monitoring, and navigation technology for future autonomy in minimally invasive diagnosis/surgery/treatment, 3D/4D image reconstruction for surgical procedures etc.